Solange Peters

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Solange Peters
Dec 4, 2024, 18:55 | Blog
Jarushka Naidoo: Join the ESMO Immuno24 next week in Geneva
Jarushka Naidoo shared a post by ESMO on X: "Join us for ESMO Immuno24 next week…
Dec 2, 2024, 09:46 | Positive
Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
As November came to a close, it's an ideal time to reflect on Lung Cancer…
Nov 30, 2024, 19:13 | Insight
Vivek Subbiah: ADC Target Expression and Interstitial Lung Disease in NSCLC
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
Nov 30, 2024, 18:14 | Blog
Valerie Yang: Harnessing the immune system has had longer and deeper benefit in Genitourinary than Lung Cancer
Valerie Yang, Consultant Medical Oncologist, National Cancer Centre Singapore, shared on LinkedIn: "Ding ding ding!!…
Nov 27, 2024, 12:16 | Blog
Evelyn Wong: A tumor-ific debate that promises to be a lung-standing discussion with kidney-shaking revelations
Evelyn Wong, Medical Oncologist at National Cancer Centre Singapore, shared a post on X: "Get…
Nov 20, 2024, 16:38 | Insight
Herbert Loong: NTRK gene fusion testing in the management of NSCLC
Herbert Loong, Chair-Elect of the International Affairs Committee of ASCO, shared a post on X…
Nov 9, 2024, 10:21 | Blog
Toni Choueiri: Our recent perspective on the next therapies in immuno-oncology trials
Toni Choueiri, Director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, posted…
Nov 8, 2024, 13:58 | Blog
Rashad Nawfal: Our work on the landscape of subsequent therapies in perioperative Immuno-oncology trials
Rashad Nawfal, Postdoctoral Research Fellow at Dana Farber Cancer Institute, shared on X about recent…
Nov 6, 2024, 12:05 | Blog
Karl Semaan: Landscape of subsequent therapies in perioperative immunotherapy trials
Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber Cancer Institute, posted on X about recent…
Oct 20, 2024, 17:47 | Drugs
Stephen V Liu: Long-term survival with nivolumab and ipilimumab in advanced NSCLC
Stephen V Liu shared on X: "Long-term survival (median f/u 73.7m) with nivolumab and ipilimumab…
Oct 6, 2024, 13:51 | Blog
The integration of cancer biomarkers allowing remarkable advancements in cancer therapeutics
Jean-Charles Soria shared a post on Linkedin: '' The integration of cancer biomarkers has revolutionized…
Oct 5, 2024, 16:04 | Societies
Highlights From ILCS24
The 6th International Lung Cancer Summit was held in Lausanne, Switzerland on October 4, 2024,…
Oct 5, 2024, 13:04 | Insight
Highlights from ILCS24 by Stephen V Liu
The 6th International Lung Cancer Summit took place as a hybrid event in Lausanne, Switzerland,…
Oct 1, 2024, 15:27 | Blog
Stephen V Liu: Eager to join the 6th International Lung Cancer Summit
Stephen V Liu posted on X: "Eager to get back to Switzerland to join the…
Sep 26, 2024, 14:08 | Blog
Celebrating 20 Years of Progress in Lung Cancer Research and Treatment - Oncogene Cancer Research
Oncogene Cancer Research shared a post on X: ''Celebrating 20 years of progress in lung…
Sep 25, 2024, 15:10 | Blog
Giannis Mountzios: Still confused after info/data overload from WCLC24 and ESMO24?
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General Hospital,…
Sep 24, 2024, 15:15 | Insight
The October issue of Nature Reviews Clinical Oncology
Diana Romero posted on LinkedIn: "The October issue of Nature Reviews Clinical Oncology was just published…
Sep 23, 2024, 12:18 | Blog
Amy C. Moore: Preview of Dr. Solange Peters’ Keynote at ILCSC24
Amy C. Moore posted the following on LinkedIn: “I just got a sneak peek of…
Sep 19, 2024, 11:50 | Insight
Toni Choueiri: The tradition of ASCO ESMO soccer tournament
Toni Choueiri shared a post on X: “Very prepared Turkish, Swiss and Dutch - they all…
Sep 10, 2024, 15:41 | Blog
OncoInfluencers to Follow on Social Media: Dr. Solange Peters
We are excited to introduce Dr. Solange Peters, a prominent figure in oncology and a…
Aug 31, 2024, 09:47 | Blog
Christian Rolfo: Excellent educational experience at Swiss Oncology Summer School
Christian Rolfo, Professor of Internal Medicine -Oncology at Ohio State University Comprehensive Cancer Center,  shared…
Aug 9, 2024, 18:04 | Insight
Meyer May-Lucie: New publication in The Lancet reviewing the treatment of advanced lung cancer
Meyer May-Lucie, Doctor at Gustave Roussy, shared on X about a recent paper titled "New…
Aug 9, 2024, 12:23 | Blog
The 6th International Lung Cancer Summit
The 6th International Lung Cancer Summit is a hybrid conference that will be held at…
Jul 21, 2024, 20:02 | Blog
Biagio Ricciuti: Join us in Lausanne for the 2024 International Lung Cancer Summit
Biagio Ricciuti shared a post on X by the International Lung Cancer Summit, adding: "Join…
Jul 19, 2024, 22:57 | Blog
Solange Peters will be the keynote speaker for LUNGevity Foundation’s ILCSC24
Amy C. Moore, VP, Global Engagement and Research Partnerships at LUNGevity Foundation, shared a post…
May 26, 2024, 08:37 | Blog
Giannis Mountzios: New Edition of the ESMO Essentials in Thoracic Oncology has officially kicked-off
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General Hospital…
May 25, 2024, 09:19 | Blog
Giannis Mountzios: Don't miss our ASCO24 session on Beyond Chemo-IO in NSCLC
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General Hospital…
May 23, 2024, 14:29 | Societies
The names of the candidates running for the ESMO Presidency 2027-2028 have been announced
The names of the candidates running for the ESMO Presidency 2027-2028 have been announced. Find…
May 19, 2024, 06:05 | Insight
Herbert Loong: Our latest recommendations for NTRK fusion testing and management in lung cancer
Herbert Loong shared on X: "We have recently published our latest recommendations for NTRK fusion…
May 12, 2024, 13:30 | Blog
Biagio Ricciuti: Insightful discussions at Rome Lung 24
Biagio Ricciuti shared a post by Stephen Liu on X and added: "Had a great…
May 12, 2024, 07:25 | Blog
Stephen Liu: Dr. Solange Peters at Rome Lung 24 with a dynamic discussion of next-generation ICIS
Stephen Liu shared on X: "Dr. Solange Peters at Rome Lung 24 with a dynamic…
May 5, 2024, 00:26 | Opinion
Peters Solange has been elected as one of the esteemed Inductee of the 2024 Class of Giants of Cancer - Oncologie | UNIL-CHUV
Oncologie | UNIL-CHUV made the following post on LinkedIn: "We are thrilled to announce that…
Mar 25, 2024, 15:15 | Societies
25 Posts Not To Miss From ELCC 2024
The European Lung Cancer Congress (ELCC 2024) took place in Prague, Czech Republic, from 20th…
Feb 26, 2024, 10:49 | Blog
Our Editor Spotlight this week is Solange Peters - ESMO Open
The Open Access journal of ESMO shared on their X/Twitter: ''Our Editor Spotlight this week is…
Feb 26, 2024, 09:51 | Blog
Hidehito Horinouchi: Thank you so much Solange Peters for coming to Japan
Hidehito Horinouchi, Medical Oncologist, Assistant Chief in the Department of Thoracic Oncology at National Cancer Center…
Feb 26, 2024, 09:45 | Blog
David Blanchard: Nice family photo of the young generation ESMO preceptorship Lung Hong-Kong 2024!
David Blanchard, Thoracic Oncologist, Professor at the University Paris Saclay, Head of the Thoracic Group…
Jan 17, 2024, 19:38 | Insight
Herbert Loong: An excellent overview of novel IO strategies in lung cancer by the amazing Solange Peters!
Herbert Loong, Clinical Associate Professor at the Chinese University of Hong Kong, shared on X/Twitter:…
Oct 24, 2023, 13:45 | Blog
Stephen V Liu: ESMO23 - Dr. Solange Peters presents the PERLA randomized phase II study
Quoting Stephen V Liu, Associate Professor of Medicine and the Director of Thoracic Oncology at Georgetown University,…
Oct 21, 2023, 19:37 | Blog
Jose Fernando Moura: Phase 2 PERLA trial shows a new option in same setting NSCLC 1st line.
Jose Fernando Moura, Oncologist and Principal Investigator in Solid Tumors at Real Hospital Portuguese and…
Oct 21, 2023, 19:09 | Societies
Evandro de Azambuja: We are over 34,000 members at ESMO
Evandro de Azambuja, ESMO Director of Membership 2023-2024, shared on his Twitter: "As the ESMO…
Sep 2, 2023, 19:28 | Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 2
Last week, on August 26, which is Women’s Equality Day in the United States, OncoDaily…
Aug 22, 2023, 09:53 | Blog
David Planchard: Amphitheater full, impressive and top organization by the ESMO staff.
Quoting David Planchard, Thoracic Oncologist and Head of Thoracic Cancer Group at Gustave Roussy, stated…
All: 42 Posts: 1 - 100
Special Coverage